Alpha 2.0
Login Register
» Articles » PMID: 35027812

Point-of-care Glucose Monitoring in COVID-19 Intensive Care Unit: How's It Different?

Overview
Journal Indian J Crit Care Med
Specialty Critical Care
Date 2022 Jan 14
PMID 35027812
Authors
Rajesh Panda
Divya Hirolli
Dalim K Baidya
Affiliations
Soon will be listed here.
Abstract

Panda R, Hirolli D, Baidya DK. Point-of-care Glucose Monitoring in COVID-19 Intensive Care Unit: How's It Different? Indian J Crit Care Med 2021;25(12):1465-1466.

References
1.
Oberg D, Ostenson C . Performance of glucose dehydrogenase-and glucose oxidase-based blood glucose meters at high altitude and low temperature. Diabetes Care. 2005; 28(5):1261. DOI: 10.2337/diacare.28.5.1261. View
2.
Johnson K, Harris C, Cain J, Hummer C, Goyal H, Perisetti A . Pulmonary and Extra-Pulmonary Clinical Manifestations of COVID-19. Front Med (Lausanne). 2020; 7:526. PMC: 7438449. DOI: 10.3389/fmed.2020.00526. View
3.
Ferri S, Kojima K, Sode K . Review of glucose oxidases and glucose dehydrogenases: a bird's eye view of glucose sensing enzymes. J Diabetes Sci Technol. 2011; 5(5):1068-76. PMC: 3208862. DOI: 10.1177/193229681100500507. View
4.
Ginsberg B . Factors affecting blood glucose monitoring: sources of errors in measurement. J Diabetes Sci Technol. 2010; 3(4):903-13. PMC: 2769960. DOI: 10.1177/193229680900300438. View
5.
Sosale A, Sosale B, Kesavadev J, Chawla M, Reddy S, Saboo B . Steroid use during COVID-19 infection and hyperglycemia - What a physician should know. Diabetes Metab Syndr. 2021; 15(4):102167. PMC: 8189750. DOI: 10.1016/j.dsx.2021.06.004. View